مدونة صيدلاوى

علاج فيرس سي المحتمل نزوله الشهر المقبل بمصر بتكلمفة 900 دولار لمدة 12 اسبوع  FDA Approves Sovaldi ® - On 6th December 2013, The U. S . Food and Drug Administration (FDA) has approved Sov aldi ® (sofosbuvir) 400 mg tablets, a once - daily oral nucleotide analogue polymerase inhibitor for the treatment of chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen . Eff icacy - E fficacy has been established in subjects wit h hepatitis C virus (HCV) genotypes 1, 2, 3 or 4 infections , and to treat HCV and HIV co-infected patients. - The combination therapy includes either riba virin (RBV) alone or Ribavirin and peg-interfero n (PEG-IFN) alfa. Drug categ ory   - Sofosbuvir acts a gainst HCV and is categorized as a Direct-Acting Antiviral agent (DAA). HCV ge no types   - Hepatitis C virus (HCV) is a major cause of chronic liver disease, with an estimated 170 million people infected world wide

AstraZeneca announced that the US Food and Drug Administration (FDA) has approved the BYDUREON Pen (exenatide extended-release for injectable suspension) 2 mg as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes. BYDUREON should not be used for treatment of patients with type 1 diabetes or diabetic ketoacidosis. BYDUREON is not recommended as first-line therapy for patients who have inadequate glycaemic control on diet and exercise. BYDUREON is not a substitute for insulin. The concurrent use of BYDUREON with insulin has not been studied and is not recommended. BYDUREON is the first and only once-weekly medicine for adults with type 2 diabetes. The BYDUREON Pen is a pre-filled, single-use pen injector, eliminating the need for the patient to transfer the medication between a vial and syringe during the self-injection process. The BYDUREON Pen contains the same formulation and dose as the original BYDUREON single-dose tray, pr

Use of Tylenol in Pregnancy Tied to Higher ADHD Risk in Child Risk increases with longer use, researchers say; experts caution the finding needs verification   Expectant mothers suffering from fever or headache may face a new dilemma when they open the medicine cabinet. Pregnant women who take acetaminophen -- best known under the brand name Tylenol -- might be more likely to have a child with attention deficit-hyperactivity disorder (ADHD), a new long-term study suggests. Acetaminophen is the most commonly used over-the-counter medication for pregnant women who experience fever or pain. Children whose mothers took acetaminophen while pregnant had up to a 40 percent higher risk of being diagnosed with ADHD, according to the research, which involved more than 64,000 Danish mothers and their children. The kids were born between 1996 and 2002. By the age of 7, these children also were more likely to use ADHD medication and exhibit ADHD-like behavior problems, according to

Researchers determined the structure of a protein on the surface of the hepatitis C virus that allows it to gain entry into cells. The finding may aid in the development of a vaccine to prevent the liver disease. Structure of the E2 core domain. Sheet B is a novel region. Image by the authors, courtesy of Nature. Hepatitis C is an infectious disease caused by a virus. The hepatitis C virus (HCV) attacks the liver, leading to inflammation. Most infections become chronic, as the body is unable to get rid of the virus. In the United States, more than 3 million people have chronic HCV infection. Worldwide, approximately 160 million people are estimated to have chronic hepatitis C. Doctors recommend that people who are at higher risk of getting hepatitis C should be tested for HCV infection. Left untreated, chronic hepatitis C can cause severe liver disease or liver cancer. If the organ becomes extremely damaged, liver failure may occur and require a transplant. Several medici